Beheshti M V, Protzer W R, Tomlinson T L, Martinek E, Baatz L A, Collins M S
Department of Radiology, Wright Patterson United States Air Force Medical Center, Wright Patterson Air Force Base, OH 45433, USA.
AJR Am J Roentgenol. 1998 Mar;170(3):731-4. doi: 10.2214/ajr.170.3.9490964.
We describe our long-term experience with radiologic implantation of the Peripheral Access System (PAS) Port venous access device. Technical efficacy and complications are documented and compared with surgical and radiologic series involving other long-term venous access devices.
Fifty-two PAS-Port catheters were implanted in 51 patients during a 30-month period. All procedures took place in the angiography suite and were performed by interventional radiologists with imaging guidance. Patients were followed up through the oncology clinic or the clinic that originally referred the patient. The durability of the catheter was evaluated, and complications were recorded during the study period.
Fifty-two ports have been indwelling for a total of 18,357 patient-days. The mean time of implantation was 372 days, with a range of 30-825 days. Technical success in implanting the device was 100%. Device-related sepsis occurred in one patient (2%), superficial thrombophlebitis in one patient (2%), skin site dehiscence in one patient (2%), and deep vein thrombosis in one patient (2%). No instances of catheter occlusion occurred, and all catheters retained the ability to aspirate blood throughout their use. The overall complication rate was 8% (0.22/1000 patient days).
Radiologic placement of this device is safe and effective. It offers many patients a superior alternative to surgically implanted chest wall ports. Complications are fewer, and chances for technical success are greater. In circumstances where cosmesis is deemed highly important, the PAS-Port device may be preferable to tunneled venous access catheters.
我们描述了外周通路系统(PAS)端口静脉通路装置放射学植入的长期经验。记录技术疗效和并发症,并与涉及其他长期静脉通路装置的外科和放射学系列进行比较。
在30个月期间,为51例患者植入了52根PAS端口导管。所有操作均在血管造影室进行,由介入放射科医生在影像引导下完成。通过肿瘤门诊或最初转诊患者的门诊对患者进行随访。评估导管的耐用性,并记录研究期间的并发症。
52个端口共留置18357个患者日。平均植入时间为372天,范围为30 - 825天。装置植入的技术成功率为100%。1例患者(2%)发生与装置相关的败血症,1例患者(2%)发生浅表血栓性静脉炎,1例患者(2%)发生皮肤部位裂开,1例患者(2%)发生深静脉血栓形成。未发生导管堵塞情况,所有导管在使用过程中均保持抽血能力。总体并发症发生率为8%(0.22/1000患者日)。
该装置的放射学放置安全有效。它为许多患者提供了一种优于手术植入胸壁端口的选择。并发症更少,技术成功的机会更大。在美观被认为非常重要的情况下,PAS端口装置可能比隧道式静脉通路导管更可取。